Products for Research Use Only
RegisterLogin

AM095

CAT: 0804-HY-16039-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-16039-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
AM095 is a selective LPA1 receptor antagonist. The IC50 for AM095 antagonism of LPA-induced calcium flux of human or mouse LPA1-transfected CHO cells is 0.025 and 0.023 μM, respectively.
CAS Number
1345614-59-6
UNSPSC
12352005
Target
LPL Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/AM095.html
Purity
99.72
Solubility
DMSO : 83.33 mg/mL (ultrasonic)
Smiles
O=C(O[Na])CC1=CC=C(C2=CC=C(C3=C(NC(O[C@@H](C4=CC=CC=C4)C)=O)C(C)=NO3)C=C2)C=C1
Molecular Formula
C27H23N2NaO5
Molecular Weight
478.47
References & Citations
[1]Swaney JS, et al. Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist. J Pharmacol Exp Ther. 2011 Mar;336 (3) :693-700.|[2]Castelino FV, et al. Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma. Arthritis Rheum. 2011 May;63 (5) :1405-15.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
LPAR1

Alternative Products

CatalogName
MBS3601385-01AM095
A13981-10AM095 10mg
A14180-25AM095 25mg
406568AM095 sodium
A14180-5AM095 5mg
A13981-100AM095 100mg
A13981-200AM095 200mg
A13981-50AM095 50mg
A13981-1AM095 1mg
A13981-500AM095 500mg

Popular Products